Our findings reveal that SALL4 is specifically required for myristoylated Akt–YAP1S127A-driven HC-to-CCA transformation, as its loss significantly suppressed malignant reprogramming and clonal expansion. Here, SALL4 is linked to cholangiocarcinoma.